youtube_live
Q3 2026 earnings • released • EPS beat +8.63%
See resultschevron_right
NOT:ETR
Novartis AG
€137.06
0.00%
(0.00) 1D
Oct 26, 5:35:42 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NOT...
Mkt. cap
321.36B
Avg. vol.
4.93K
Volume
0.00
52-wk high
€144.12
52-wk low
€104.52
No. of employees
75K
Mkt. cap
321.36B
Avg. vol.
4.93K
Volume
0.00
52-wk high
€144.12
52-wk low
€104.52
No. of employees
75K
News stories
From web sources and news partners
Investing.com
·
10 minutes ago
Novartis ADR earnings beat by $0.18, revenue fell short of estimates
WSJ
·
45 minutes ago
Novartis Raises Guidance Despite Trial Setbacks Hitting Profit
www.tokenpost.com
·
47 minutes ago
Novartis Raises 2026 Core Operating Income Outlook After Q3 Core EPS Rises 9%
Investing.com
·
54 minutes ago
Novartis raises annual profit outlook after strong Q3 sales growth
Profile
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
About Novartis AG
CEOVasant Narasimhan
Employees75.3K
FoundedMar 7, 1996
HeadquartersBasel, Basel City, Switzerland
SectorPharmaceutical industry
Websitenovartis.com